Expression of mitochondrial Apo2.7 molecules and caspase-3 activation in human lymphocytes treated with the ribosome-inhibiting mistletoe lectins andthe cell membrane permeabilizing viscotoxins
A. Bussing et al., Expression of mitochondrial Apo2.7 molecules and caspase-3 activation in human lymphocytes treated with the ribosome-inhibiting mistletoe lectins andthe cell membrane permeabilizing viscotoxins, CYTOMETRY, 37(2), 1999, pp. 133-139
Background: It is unclear whether expression of newly described mitochondri
al Apo2.7 molecules (7A6 antigen) is specific for apoptosis or may also occ
ur in necrosis.
Methods: We incubated human lymphocytes with the apoptosis-inducing mistlet
oe lectin (ML) I and the cell membrane-permeabilizing viscotoxins (VT), and
measured cell death-associated changes by flow cytometry.
Results: In ML I-treated lymphocytes, Apo2.7 expression and caspase-3 activ
ation was recognized within 24 h. In VT-treated cells, we observed an Apo2.
7 expression with low fluorescence level, while active caspase-3 and DNA fr
agments (TUNEL) were not detected within 24 h. In these cells, caspase-3 ac
tivation was recognized 48 h later. As a major subset of ML-treated cells e
xpressing Apo2.7 molecules did not activated caspase-3, while all caspase-3
(+) cells did express Apo2.7, one may suggest that the caspase pathway is a
ctivated secondarily to mitochondrial events.
Conclusions: Expression of Apo2.7 is sensitive marker of cell death but may
not be specific for apoptosis alone as it can be detected also in cells tr
eated with cell membrane-permeabilizing toxins. On the other hand, this exp
ression may be the consequence of an induction of distinct "death signals"
resulting in apoptosis later on. Cytometry 37: 133-139, 1999. (C) 1999 Wile
y-Liss, Inc.